Cardiovascular outcomes of treat-to-target vs fire-and-forget urate-lowering therapy in patients with gout starting urate-lowering therapy. An emulated multicentre open-label two-parallel arm superiority trial carried out in primary care

Study identification

• EU PAS number:
  EUPAS1000000086
• Study ID:
  1000000086
• Official title and acronym:
  Cardiovascular outcomes of treat-to-target vs fire-and-forget urate-lowering therapy in patients with gout starting urate-lowering therapy. An emulated multicentre open-label two-parallel arm superiority trial carried out in primary care
• DARWIN EU® study:
  No
• Study countries:
  Sweden

  United Kingdom
• Study status:
  Planned

Research institutions and networks

Institutions

The University of Nottingham

University of Gothenburg

Study timelines

Date when funding contract was signed

Planned: 01/09/2023

Study start date

Planned: 01/05/2024

Data analysis start date

Planned: 01/05/2024

Date of final study report

Planned: 01/09/2024

Sources of funding

Non-for-profit organisation (e.g. charity)

More details on funding

This project was supported by a research grant from the Foundation for Research in Rheumatology (FOREUM). The funder had no role in study design, data collection, data analysis, data interpretation or writing of the report.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable